Beta Bionics (BBNX) Income from Continuing Operations (2024 - 2026)

Beta Bionics has disclosed Income from Continuing Operations across 3 years of filings, most recently posting 21895000.0 for Q1 2026.

• Income from Continuing Operations for Q1 2026 came in at 21895000.0, down 35.1% year-over-year; the trailing twelve-month figure through Mar 2026 was 66438000.0 (down 34.94% YoY), and the FY2025 annual result was 60749000.0, down 46.94% from the prior year.
• Income from Continuing Operations came in at 21895000.0 for Q1 2026 at Beta Bionics, down from 13466000.0 in the prior quarter.
• In the past five years, Income from Continuing Operations ranged from a high of 8314000.0 in Q1 2024 to a low of 21895000.0 in Q1 2026.
• The 3-year median for Income from Continuing Operations is 13466000.0 (2025), against an average of 13776222.22.
• Peak annual rise in Income from Continuing Operations reached 11.42% in 2025, while the deepest fall reached 94.92% in 2025.
• Beta Bionics' Income from Continuing Operations stood at 12086000.0 in 2024, then declined by 11.42% to 13466000.0 in 2025, then slumped by 62.59% to 21895000.0 in 2026.
• The last three Income from Continuing Operations figures came in at 21895000.0 (Q1 2026), 13466000.0 (Q4 2025), and 14210000.0 (Q3 2025), per Business Quant data.